
501 - 1000 employees
Founded 2014
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 $350M Post-IPO Equity - Autolus on 2024-02
Healthcare • Consulting • Manufacturing
Autolus Therapeutics is a clinical-stage biotechnology company developing next-generation autologous CAR T cell therapies for cancer and autoimmune diseases. The company applies advanced cell programming, proprietary viral vectors, and semi-automated T cell manufacturing to engineer precision CAR T products, and is advancing a pipeline that includes programs for hematological malignancies, solid tumors, and autoimmune indications. Autolus emphasizes integrated development and commercialization efforts, clinical trials, and publication of its research.
🕒 5 days ago
Cell therapy account executive managing treatment-center relationships for Autolus, a biopharmaceutical company developing programmed T-cell therapies. Driving CAR-T utilization and clinical coordination across Massachusetts and Greater New England.
🍂 Massachusetts – Remote
💵 $182k - $240k / year
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🕒 August 13
Cell therapy account executive driving CAR-T adoption and treatment-center relationships for Autolus, a biopharmaceutical company developing programmed T-cell therapies. Coordinating clinical logistics, stakeholder education, strategic accounts, and cross-functional commercial activities across the U.S. Midwest.
🏰 Missouri – Remote
💵 $182k - $240k / year
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🕒 August 12
Cell therapy account executive managing Autolus treatment-center relationships and CAR-T utilization. Supporting clinical operations, stakeholder education, and strategic account growth for cancer therapies.
🦀 Maryland – Remote
💵 $182k - $240k / year
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🕒 August 12
Payer access director securing coverage and reimbursement for Autolus’ cancer and autoimmune cell therapies. Managing payer relationships, treatment-center onboarding, and market-access strategy across the United States.
❄️ Minnesota – Remote
💵 $194k - $260k / year
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🔴 Lead
😶🌫️ Therapist
👻 Ghost score 0%
🕒 August 5
Corporate Paralegal supporting SEC filings, state registrations, and corporate governance. Providing legal support for Autolus, a biopharmaceutical company developing programmed T-cell therapies for cancer and autoimmune disease.
🌪️ Oklahoma, Maryland, +3 more states – Remote
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
💼 Paralegal
👻 Ghost score 12%
🕒 July 31
MSL engaging with external stakeholders in oncology to inform practice, improve patient access, and support clinical trials. Collaborating with field colleagues to leverage medical intelligence.
🍂 Massachusetts – Remote
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
👻 Ghost score 12%
🕒 July 24
Cell Therapy Account Executive responsible for building relationships with oncology treatment centers. Driving utilization of CAR T therapies for cancer treatment in the US West Coast region.
⛰️ Colorado, Oregon, +1 more states – Remote
💵 $182k - $240k / year
💰 $350M Post-IPO Equity - Autolus on 2024-02
⏰ Full Time
🟠 Senior
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%